Cormorant Asset Management’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-402,200
| Closed | -$10.8M | – | 82 |
|
|
2022
Q1 | $10.8M | Sell |
402,200
-97,800
| -20% | -$2.61M | 0.83% | 36 |
|
|
2021
Q4 | $14.7M | Buy |
500,000
+150,000
| +43% | +$4.4M | 0.87% | 33 |
|
|
2021
Q3 | $23M | Buy |
350,000
+100,000
| +40% | +$6.58M | 0.94% | 32 |
|
|
2021
Q2 | $20.8M | Sell |
250,000
-245,769
| -50% | -$20.4M | 0.71% | 37 |
|
|
2021
Q1 | $38M | Sell |
495,769
-104,231
| -17% | -$7.99M | 0.85% | 26 |
|
|
2020
Q4 | $53M | Buy |
600,000
+375,000
| +167% | +$33.1M | 1.26% | 25 |
|
|
2020
Q3 | $16.6M | Sell |
225,000
-115,146
| -34% | -$8.5M | 0.64% | 39 |
|
|
2020
Q2 | $24.8M | Sell |
340,146
-85,958
| -20% | -$6.28M | 0.95% | 30 |
|
|
2020
Q1 | $23.9M | Buy |
426,104
+269,704
| +172% | +$15.1M | 1.11% | 25 |
|
|
2019
Q4 | $5.97M | Hold |
156,400
| – | – | 0.24% | 51 |
|
|
2019
Q3 | $2.78M | Buy |
+156,400
| New | +$2.78M | 0.17% | 58 |
|